40 million bivalent vax doses seen enough for priority groups
Up to 40 million doses of bivalent COVID-19 vaccines will be sufficient to protect priority groups as there is “no urgent need” to give boosters to majority of the country’s population. House health panel vice chair Rep. Angelica Natasha Co said the Department of Health “need not acquire too many stocks of bivalent vaccines” targeting […]
The post 40 million bivalent vax doses seen enough for priority groups appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.